Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IIOngoingApr 2, 2025fentaNYL Citrate PF 200 mcg/100 mLLack of Assurance of SterilityQuVa Pharma, Inc. · D-0296-2025Class IIOngoingApr 2, 2025fentaNYL Citrate PF 200 mcg/100 mLLack of Assurance of SterilityQuVa Pharma, Inc. · D-0295-2025Class IICompletedApr 2, 2025Testosterone Gel 1%Presence of foreign substance: Presence of Benzene.Strides Pharma, Inc. · D-0294-2025Class IICompletedApr 2, 2025Testosterone Gel 1%Presence of foreign substance: Presence of Benzene.Strides Pharma, Inc. · D-0293-2025Class IICompletedApr 2, 2025METFORMIN HYDROCHLORIDE EXTENDED- RELEASE 500MGPresence of Foreign Tablets/Capsules.A-S Medication Solutions LLC · D-0292-2025Class IIOngoingMar 26, 2025Levothyroxine Sodium TabletsSuper-Potent Drug: Out of specification potency results were obtained.Mylan Institutional, Inc. · D-0291-2025Class IIOngoingMar 26, 2025Levothyroxine Sodium TabletsSuper-Potent Drug: Out of specification potency results were obtained.Mylan Institutional, Inc. · D-0290-2025Class IIOngoingMar 26, 2025CURAD Alcohol Prep PadsSubpotent DrugMEDLINE INDUSTRIES, LP - Northfield · D-0289-2025Class IIOngoingMar 26, 2025Medline Alcohol Prep PadsSubpotent DrugMEDLINE INDUSTRIES, LP - Northfield · D-0288-2025Class IIOngoingMar 26, 2025PRASUGREL TABLETSFailed Dissolution SpecificationsGolden State Medical Supply Inc. · D-0287-2025Class IIOngoingMar 26, 2025NeupogenStability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.Amgen, Inc. · D-0286-2025Class IIOngoingMar 26, 2025NeupogenStability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.Amgen, Inc. · D-0285-2025Class IIOngoingMar 26, 2025CVS Health Concealing Acne Treatment CreamChemical contamination: presence of benzeneFruit Of The Earth, Inc. · D-0284-2025Class IIOngoingMar 26, 2025Walgreens Maximum Strength Tinted Acne Treatment Cream 10% Benzoyl Peroxide/Acne MedicationChemical contamination: presence of benzeneFruit Of The Earth, Inc. · D-0283-2025Class IIOngoingMar 26, 2025Ciprofloxacin Ophthalmic Solution USPDefective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottleFDC Limited · D-0282-2025Class IOngoingMar 26, 2025VitalityMarketed without an approved NDA/ANDA: Product found to be tainted with undeclared sildenafil and tadalafil.One Source Nutrition, Inc, · D-0281-2025Class IIOngoingMar 26, 2025Prasugrel TabletsFailed Dissolution Specifications - low dissolution resultsMylan Pharmaceuticals Inc · D-0280-2025Class IICompletedMar 26, 2025Cinacalcet Hydrochloride Tablets 60 mgCGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.Slate Run Pharmaceuticals · D-0279-2025Class IICompletedMar 26, 2025Cinacalcet Hydrochloride Tablets 30 mgCGMP deviations: The presence of nitrosamine impurity above the acceptable daily intake limits.Slate Run Pharmaceuticals · D-0278-2025Class IIOngoingMar 26, 2025Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit.Rising Pharma Holding, Inc. · D-0277-2025Class IIOngoingMar 19, 2025Kids by babyganics SPF 50 mineral sunscreen totally tropicalChemical ContaminationJohnson, S C and Son, Inc · D-0276-2025Class IIOngoingMar 19, 2025Kids by babyganics SPF 50 totally tropicalChemical ContaminationJohnson, S C and Son, Inc · D-0275-2025Class IIOngoingMar 19, 2025WalgreensChemical Contamination: Presence of benzeneSigan Industries Group Inc. · D-0274-2025Class IIOngoingMar 19, 2025Zapzyt, Acne Treatment GelChemical Contamination: Presence of benzene.Denison Pharmaceuticals, LLC · D-0273-2025Class IOngoingMar 19, 2025PHENYLephrine added to 0.9% sodium chloridePresence of Particulate MatterCentral Admixture Pharmacy Services, Inc. · D-0272-2025Class IIOngoingMar 19, 2025Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.Breckenridge Pharmaceutical, Inc. · D-0271-2025Class IIOngoingMar 19, 2025Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.Breckenridge Pharmaceutical, Inc. · D-0270-2025Class IIOngoingMar 19, 2025Duloxetine Delayed-Release CapsulesCGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.Breckenridge Pharmaceutical, Inc. · D-0269-2025Class IOngoingMar 19, 2025POTASSIUM CHLORIDE InjLabeling: Label Error on Declared Strength. Overwrap labeled as Potassium Chloride Inj 10 mEq may contain flexible containers of Potassium Chloride Inj 20 mEqICU Medical, Inc. · D-0268-2025Class IOngoingMar 19, 2025POTASSIUM CHLORIDE InjLabeling: Label Error on Declared Strength. Cases labeled POTASSIUM CHLORIDE 20 mEq, may contain flexible containers with overwrap mislabeled as 10 mEq. The correct...ICU Medical, Inc. · D-0267-2025Class IIOngoingMar 19, 2025Unisom, SleepMeltsCGMP Deviations: Nitrosamine Drug Substance Related Issue impurity above the daily acceptable intake limit defined by the Food and Drug Administration.Chattem Inc · D-0266-2025Class IIOngoingMar 19, 2025Voriconazole Container Description: voriconazole The product packed in white poly bag containing black poly...CGMP DeviationsAspen Biopharma Labs Pvt., Ltd. · D-0265-2025Class IIOngoingMar 19, 2025LatanoprostCGMP DeviationsAspen Biopharma Labs Pvt., Ltd. · D-0264-2025Class IIOngoingMar 19, 2025Chlorambucil Container Description: The product packed in double self-seal cover and finally packed in...CGMP DeviationsAspen Biopharma Labs Pvt., Ltd. · D-0263-2025Class IIOngoingMar 19, 2025FinasterideCGMP DeviationsAspen Biopharma Labs Pvt., Ltd. · D-0262-2025Class IIOngoingMar 19, 2025Alprostadil Container Description: Amber color bottleCGMP DeviationsAspen Biopharma Labs Pvt., Ltd. · D-0261-2025Class IIOngoingMar 19, 2025BimatoprostCGMP DeviationsAspen Biopharma Labs Pvt., Ltd. · D-0260-2025Class IOngoingMar 19, 2025BD ChloraPrep Clear 1mL ApplicatorsNon-Sterility: contamination of Aspergillus penicillioides, due to breach in package lidding.CareFusion 213, LLC · D-0259-2025Class IIICompletedMar 19, 2025Livalo (pitavatstatin) tabletsPresence of foreign tablets/capsulesKowa Pharmaceuticals America · D-0258-2025Class IITerminatedMar 19, 2025Sodium Chloride Injection 9%Lack of Assurance of Sterility: There is a potential for leakage at the IV bottle port.Nephron Sterile Compounding Center LLC · D-0257-2025

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.